We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.91B
1-Year Est. Return 31.75%
This Fund
S&P 500
This Quarter Est. Return
+18.7%
1 Year Est. Return
+31.75%
3 Year Est. Return
+92.45%
5 Year Est. Return
+115.62%
10 Year Est. Return
+448.61%
AUM
$4.91B
AUM Growth
+$562M
Cap. Flow
+$22.4M
Cap. Flow %
0.46%
Top 10 Hldgs %
29.56%
Holding
867
New
131
Increased
229
Reduced
246
Closed
104

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.53%
2 Technology 23.02%
3 Financials 7.42%
4 Healthcare 6.43%
5 Communication Services 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALKS icon
726
Alkermes
ALKS
$7.73B
$211K ﹤0.01%
+4,025
New +$157K
ZVRA icon
727
Zevra Therapeutics
ZVRA
$736M
$211K ﹤0.01%
14,700
SRLN icon
728
State Street Blackstone Senior Loan ETF
SRLN
$5.47B
$208K ﹤0.01%
+5,166
New +$209K
EVER icon
729
EverQuote
EVER
$878M
$207K ﹤0.01%
+8,700
New +$159K
VCYT icon
730
Veracyte
VCYT
$3.42B
$205K ﹤0.01%
+3,488
New +$146K
EFSC icon
731
Enterprise Financial Services Corp
EFSC
$2.34B
$204K ﹤0.01%
3,100
-11,800
-79% -$710K
REG icon
732
Regency Centers
REG
$13.8B
$204K ﹤0.01%
+2,561
New +$201K
GIC icon
733
Global Industrial
GIC
$1.52B
$204K ﹤0.01%
6,100
-13,700
-69% -$435K
IWB icon
734
iShares Russell 1000 ETF
IWB
$49B
$203K ﹤0.01%
+495
New +$196K
STT icon
735
State Street
STT
$53.4B
$201K ﹤0.01%
+1,188
New +$183K
IR icon
736
Ingersoll Rand
IR
$29.6B
$201K ﹤0.01%
+2,456
New +$190K
ARTV
737
Artiva Biotherapeutics
ARTV
$547M
$201K ﹤0.01%
20,700
SFIX
738
Stitch Fix
SFIX
$407M
$197K ﹤0.01%
+48,000
New +$175K
HLN icon
739
Haleon
HLN
$42.2B
$196K ﹤0.01%
20,979
GO icon
740
Grocery Outlet
GO
$1.23B
$193K ﹤0.01%
19,289
ASPN icon
741
Aspen Aerogels
ASPN
$408M
$187K ﹤0.01%
+29,508
New +$145K
HOFT icon
742
Hooker Furnishings Corp
HOFT
$141M
$184K ﹤0.01%
+10,300
New +$141K
SLP icon
743
Simulations Plus
SLP
$373M
$183K ﹤0.01%
10,000
FRSH icon
744
Freshworks
FRSH
$3.32B
$167K ﹤0.01%
+16,500
New +$147K
CPIX icon
745
Cumberland Pharmaceuticals
CPIX
$102M
$160K ﹤0.01%
+24,624
New +$118K
ORMP icon
746
Oramed Pharmaceuticals
ORMP
$208M
$156K ﹤0.01%
32,478
SPT icon
747
Sprout Social
SPT
$688M
$152K ﹤0.01%
+20,100
New +$131K
PBYI icon
748
Puma Biotechnology
PBYI
$493M
$147K ﹤0.01%
18,100
PLX icon
749
Protalix BioTherapeutics
PLX
$215M
$142K ﹤0.01%
+61,100
New +$129K
CLYM
750
Climb Bio
CLYM
$891M
$142K ﹤0.01%
+10,900
New +$113K

Similar funds

Bailard's Q2 2026 Portfolio in Review

As of Q2 2026, Bailard held 867 positions worth $4.91B, up 13% from $4.35B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bailard's Q2 2026 filing shows 131 new, 229 increased, 246 reduced and 104 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 240,655 shares worth $12.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $89.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 42% a quarter earlier, followed by Technology and Financials.

  • Bailard's largest Q2 2026 buy was iShares Floating Rate Bond ETF: 240,655 shares worth $12.3M.
  • Bailard added most to iShares Russell 2000 Value ETF in Q2 2026, an estimated $87.5M increase.
  • Bailard's biggest Q2 2026 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $89.5M.
  • Bailard fully exited Putnam Sustainable Leaders ETF in Q2 2026, selling an estimated $2.1M.
  • Bailard's ten largest holdings make up 30% of its $4.91B portfolio in Q2 2026.
  • Bailard opened 131 new positions and closed 104 in Q2 2026.
  • Bailard's portfolio value rose 13% quarter-over-quarter to $4.91B.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.